Mediheal Expanded Skin Care Line in Japan
The company moved beyond its signature sheet masks to launch a full Derma Skin Care Series in August 2026.
Updated on Oct. 14, 2026 in Beauty
Live Poll
Do you trust established brands to maintain quality when they expand into new product types?
Mediheal officially expanded its global product portfolio in August 2026 with the introduction of its new Derma Skin Care Series in Japan. This move marks a strategic shift for the brand as it moves from its heritage of sheet masks into comprehensive daily skin care solutions.
Why it matters
The transition aims to support consumer needs throughout every step of a daily beauty routine while capitalizing on the brand's established international presence. By leveraging high-purity ingredients, Mediheal seeks to build upon the significant sales growth it recorded in 2025.
Mediheal products feature ingredients with purity levels exceeding 99 percent and are currently sold across 43,000 retail stores in Japan. The brand has already sold over 3.1 billion sheet masks as of 2025.
The players
Mediheal
This beauty brand is a subsidiary of L&P Cosmetic known for its extensive range of sheet masks and skin care products.
Kwon Oh-sub
He is the Chairman of L&P Cosmetic who oversees the company's global expansion and product strategy.
Kolmar Korea
This company is an original development manufacturer that collaborates with beauty brands on product planning.
Cosmax
This is a global research and development manufacturer that partners with cosmetic companies to produce skincare solutions.
The details
The new lineup features toners, serums, cleansers, creams, and sun care products formulated with tea tree, madecassoside, and polydeoxyribonucleotide. Mediheal utilizes its patented FLEX-SOME technology to boost ingredient absorption and collaborates with Kolmar Korea and Cosmax for product planning.
Timeline
Chairman Kwon Oh-sub sold his first mask label, Clinie, in 2009.
Mediheal officially entered the Japanese market in 2017.
The brand began testing its skin care lineup expansion in 2022.
Annual sales reached 200 billion won at Olive Young in 2025.
The Derma Skin Care Series was introduced in Japan in August 2026.
Culture Shift
Mediheal's move tracks the broader transition in the K-beauty sector from niche, single-use mask products toward comprehensive, science-backed multi-step derma-cosmetic regimens. This evolution reflects a growing consumer preference for cohesive skin care solutions over standalone novelty products.
Consumers can expect to find the new Derma Skin Care Series transitioning from digital storefronts into physical variety and general retail stores. This rollout expands the accessibility of Mediheal’s high-purity serums and creams for shoppers looking to integrate the brand into their full daily routine.
The takeaway
The success of Mediheal’s Madecassoside Blemish Repair Serum, which saw 820 percent growth, underscores the strong consumer demand for targeted, science-based skin care. Readers may find that moving toward a cohesive brand system can improve ingredient synergy and consistency in their daily routines.
What happens next
Chairman Kwon Oh-sub plans to increase annual factory price sales to 2 trillion won, while the brand intends to expand the availability of its Derma Skin Care Series from online platforms into variety and general retail stores.
Further reading
For more information on the evolving cosmetics landscape, visit the Beauty section.
Source note: This article includes information reported by The Korea Times.
Live Poll
Do you trust established brands to maintain quality when they expand into new product types?
